Vaccines

Vaccines

Rabies Infection Pipeline Insight 2025: Monoclonal Antibodies, Novel Vaccines, and Antiviral Platforms Drive Innovation

The rabies infection pipeline is rapidly advancing, with novel approaches aiming to improve prevention and post-exposure care. Despite the effectiveness of current post-exposure prophylaxis (PEP) with vaccines and immunoglobulin, limited access, high costs, and a lack of treatment for symptomatic cases underscore a significant unmet need. The therapeutic pipeline is